Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Buprenorphine 200microgram sublingual tablets sugar free |
BNF code | 0407020B0AAABAB |
Virtual Therapeutic Moiety | Buprenorphine |
Date identifier became valid | 3 Jul 2023 |
Previous product identifier | 322498006 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 6 Jan 2005 |
Previous name | Buprenorphine 200microgram sublingual tablets |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✓ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Buprenorphine hydrochloride |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 387173000 |
Strength value numerator | 200.000 |
Strength value numerator unit | microgram |
Ontology Drug Form & Route | |
Form & Route | tabletsublingual.oromucosal |
Dose Form | |
Formulation | Sublingual tablet |
Drug Route | |
Route | Sublingual |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 3 (CD No Register) |
Actual Medicinal Products | |
Temgesic 200microgram sublingual tablets (Eumedica Pharma Ltd) | |
Tephine 200microgram sublingual tablets (Sandoz Ltd) | |
Virtual Medicinal Product Packs | |
Buprenorphine 200microgram sublingual tablets sugar free 50 tablet |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.